COVID-19 Clinical Trials in Houston, Texas
19 recruitingHouston, Texas
Showing 1–19 of 19 trials
Recruiting
Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 (SARS-CoV-2) infection
Pfizer2,330 enrolled246 locationsNCT06679140
Recruiting
Phase 3
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Pfizer300 enrolled147 locationsNCT07013474
Recruiting
Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled224 locationsNCT06667700
Recruiting
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection
M.D. Anderson Cancer Center600 enrolled1 locationNCT04551378
Recruiting
Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922
Recruiting
Phase 3
Study of VYD2311 for the Prevention of COVID-19
COVID-19
Invivyd, Inc.1,770 enrolled20 locationsNCT07298434
Recruiting
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
Invasive Breast CarcinomaBreast Ductal Carcinoma in SituHereditary Breast Carcinoma+1 more
M.D. Anderson Cancer Center600 enrolled4 locationsNCT04169542
Recruiting
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
MelanomaCOVID-19 Infection
M.D. Anderson Cancer Center1,152 enrolled1 locationNCT04474301
Recruiting
Phase 1
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed+4 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT05101213
Recruiting
Phase 1Phase 2
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection+2 more
M.D. Anderson Cancer Center70 enrolled1 locationNCT04565665
Recruiting
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
The Impact of COVID-19 on Pulmonary Procedures
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection
M.D. Anderson Cancer Center250 enrolled1 locationNCT05022446
Recruiting
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
COVID-19 Infection
M.D. Anderson Cancer Center20,000 enrolled1 locationNCT04491292
Recruiting
Not Applicable
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
Coping SkillsEmotional DistressSocial Support+2 more
University of Illinois at Urbana-Champaign800 enrolled9 locationsNCT05639465
Recruiting
Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
COVID-19
BioNTech SE25,500 enrolled208 locationsNCT07300839
Recruiting
Not Applicable
Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
COVID-19
The University of Texas Health Science Center, Houston150 enrolled1 locationNCT06821113
Recruiting
Phase 1
Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine
Vaccine ResponseImmune Response to Covid 19 VaccinationCOVID-19 vaccine
The Methodist Hospital Research Institute75 enrolled1 locationNCT06821100
Recruiting
Phase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
COVID-19
Pfizer160 enrolled73 locationsNCT05261139
Recruiting
COVID-19 Outcome Prediction Algorithm
Frailty SyndromeCOVID-19Post Acute Sequelae of COVID-19+2 more
University of California, Los Angeles600 enrolled7 locationsNCT05471011